Interestingly, we found that the acetylated K88 in MTHFD2 is dramatically decreased in tumor samples comparing with adjacent normal tissues, implying that targeting the acetylated K88 in MTHFD2 might be a potential approach for colorectal cancer treatment. This evidence concerns the gene MTHFD2 and colorectal cancer.